Study to compare Dexmedetomidine with Midazolam as Sedative Agent in Medical Thoracoscopy.

Randomized Control Study to compare the utility of Dexmedetomidine with Midazolam for conscious sedation in Medical Thoracoscopy - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072071

Enrollment

Registered

2024-08-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: Inj.Dexmedetomidine 1 mcg/kg will be given intravenously over 10 minutes as loading dose before the initiation of the procedure, followed by maintenance infusion dose o

Eligibility

Inclusion criteria

Inclusion criteria: Patients with pleural effusion undergoing medical thoracoscopy,Age 18years to 80years

Exclusion criteria

Exclusion criteria: Age less than 18 years,patients with known allergy or contraindication to study drugs,patients who donot give consent

Design outcomes

Primary

Measure	Time frame
To compare pulmonologist rated overall satisfaction on visual analogue scale for patients undergoing medical thoracoscopy under conscious sedation between dexmeditomedine and midazolamTimepoint: 1hour	—

Secondary

Measure	Time frame
to compare the lowest mean oxygen saturation ,patient rated pain score for patients undergoing medical thoracoscopy under conscious sedation between dexmeditomedine and midazolamTimepoint: 1h	—

Countries

India

Contacts

Public ContactK Surendar Reddy

ESIC Medical college Hospital ,Hyderabad

surendark918@gmail.com9700565999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026